PCSK9 inhibitors in the management of atherosclerotic cardiovascular disease: Current clinical trials and future directions

被引：0
|
作者：
Nie, Wenyi [1 ]
Yue, Yingbin [2 ,3 ]
Hu, Jingqing [1 ]
机构：
[1] Changchun Univ Chinese Med, Changchun 130117, Peoples R China
[2] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi 830054, Peoples R China
[3] Xinjiang Med Univ, State Key Lab Pathogenesis, Prevent & Treatment High Incidence Dis Cent Asia, Urumqi 830054, Peoples R China
来源：
ATHEROSCLEROSIS | 2024年 / 399卷
基金：
国家重点研发计划;
关键词：
PCSK9; inhibitors; Clinical trial; Existing evidence; Future perspectives;
D O I：
10.1016/j.atherosclerosis.2024.119043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] PCSK9 INHIBITORS: HOPE FOR THE FUTURE OR REALITY?
    Bellino, M.
    Scicchitano, P.
    Agea, A.
    Cecere, A.
    Cortese, F.
    Massari, F.
    Caldarola, P.
    Ciccone, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E104 - E104
  • [42] PCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic era
    Chapman, M. John
    Stock, Jane K.
    Ginsberg, Henry N.
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (06) : 511 - 520
  • [43] PCSK9 inhibitors - past, present and future
    Reiner, Zeljko
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (10) : 1517 - 1521
  • [44] PCSK9 inhibitors as safer therapeutics for atherosclerotic cardiovascular disease (ASCVD): Pharmacophore design and molecular dynamics analysis
    Kehinde, Ibrahim O.
    Akawa, Oluwole
    Adewumi, Adeniyi T.
    Rabbad, Ali H.
    Soliman, Mahmoud E. S.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2024, 125 (07)
  • [45] PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention
    Paciullo, Francesco
    Momi, Stefania
    Gresele, Paolo
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (03) : 359 - 367
  • [46] Lipids and lipid lowering: current management with statins and PCSK9 inhibitors
    Luescher, Thomas F.
    EUROPEAN HEART JOURNAL, 2018, 39 (14) : 1117 - 1120
  • [47] Role of PCSK9 inhibitors in the management of dyslipidaemia
    Nair, Tiny
    INDIAN HEART JOURNAL, 2024, 76 : S44 - S50
  • [48] Cholesterol Management in the Era of PCSK9 Inhibitors
    Svatikova, Anna
    Kopecky, Stephen L.
    CURRENT CARDIOLOGY REPORTS, 2017, 19 (09)
  • [49] Cholesterol Management in the Era of PCSK9 Inhibitors
    Anna Svatikova
    Stephen L. Kopecky
    Current Cardiology Reports, 2017, 19
  • [50] Inhibitors of PCSK9 and dyslipidemia: the clinical evidence
    Norata, Giuseppe Danilo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2014, 15 (05) : 301 - 305
12345